title: Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.
authors.forename: María C
authors.initials: MC
authors.lastname: Matute
authors.forename: Marta
authors.initials: M
authors.lastname: Guillán
authors.forename: Juan
authors.initials: J
authors.lastname: García-Caldentey
authors.forename: Javier
authors.initials: J
authors.lastname: Buisan
authors.forename: María
authors.initials: M
authors.lastname: Aparicio
authors.forename: Jaime
authors.initials: J
authors.lastname: Masjuan
authors.forename: María
authors.initials: M
authors.lastname: Alonso de Leciñana
mesh_terms: D000368:Aged; D000991:Antithrombins / Q000008:administration & dosage / Q000009:adverse effects*; D001037:Aphasia; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D002340:Carotid Artery Diseases / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery; D000069604:Dabigatran; D005260:Female; D005592:Fracture Fixation; D006429:Hemiplegia; D006470:Hemorrhage / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D007511:Ischemia; D011183:Postoperative Complications; D017410:Practice Guidelines as Topic; D011475:Prosthesis Failure / Q000009:adverse effects*; D012306:Risk; D020521:Stroke / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology / Q000601:surgery; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control; D015091:beta-Alanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran